A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
about
Posterior reversible leukoencephalopathy syndrome after kratom ingestion.Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience.Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.Assessment of tolerance to the effects of methamphetamine on daytime and nighttime activity evaluated with actigraphy in rhesus monkeys.Overweight in Boys With ADHD Is Related to Candidate Genes and Not to Deficits in Cognitive Functions.Behavioural and emotional disorders in childhood: A brief overview for paediatricians.Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners.Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study.
P2860
Q33788789-22FA23CC-4732-4B98-A403-6DB113B19703Q38664308-33941665-2C8C-44F8-8D6B-3DD34D220557Q39220718-0DD1D8DE-D80A-42E3-9720-34140F565B92Q41595301-186D3B1A-C951-491B-A11D-D3856134B235Q42339253-9FE737F0-108F-4C8F-9D50-A846DD3C7C1BQ47644292-9025C4BF-8F2B-466B-A683-84345FF113C6Q47723232-DF9F155C-E09B-41D2-9DDD-F37BE990E7BCQ48747282-9D228434-C56E-4FAC-897A-232ACA4124A0Q49873437-F3CE72A5-1258-4209-9A21-E413219545B3Q50021450-B54266F5-9B61-4AA3-AD40-04ACBCA69054Q52594335-D239D078-4CFD-4C67-9A33-36E9B6CDC910
P2860
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@ast
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@en
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@nl
type
label
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@ast
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@en
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@nl
prefLabel
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@ast
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@en
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@nl
P2860
P921
P1476
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder
@en
P2093
Leslie Briars
Timothy Todd
P2860
P304
P356
10.5863/1551-6776-21.3.192
P407
P577
2016-01-01T00:00:00Z